Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.accesswire.com/854362/cantargia-publishes-annual-report-for-2023
https://www.accesswire.com/854326/notice-of-annual-general-meeting-in-cantargia-ab-publ
https://www.accesswire.com/853998/cantargia-publishes-new-data-on-the-can10-antibody-detailing-its-interaction-with-il1rap-and-functional-inhibition
https://www.accesswire.com/851885/cantargia-publishes-preclinical-data-on-the-potential-of-can10-in-systemic-sclerosis-in-a-leading-scientific-journal
https://www.accesswire.com/851253/cantargia-presents-unique-effects-of-nadunolimab-in-pancreatic-cancer
https://www.accesswire.com/849080/cantargia-publishes-data-highlighting-the-potential-of-can10-in-atherosclerosis
https://www.accesswire.com/847314/cantargia-reports-progress-towards-start-of-dod-sponsored-clinical-trial-of-nadunolimab-in-leukemia